180 related articles for article (PubMed ID: 11459283)
21. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
22. [Long term survival after pancreatic resection for pancreatic adenocarcinoma].
Wirtz M; Friess H
Z Gastroenterol; 2002 Sep; 40(9):849-52. PubMed ID: 12215954
[No Abstract] [Full Text] [Related]
23. [Concomitant chemoradiotherapy and preoperative radiotherapy in exocrine pancreatic adenocarcinoma].
Mornex F; Gérard JP; Chauffert B; Brun M
Ann Chir; 2000 Feb; 125(2):111-7. PubMed ID: 10998795
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.
Aristu J; Cañón R; Pardo F; Martínez-Monge R; Martin-Algarra S; Manuel Ordoñez J; Villafranca E; Moreno M; Cambeiro M; Azinovic I
Am J Clin Oncol; 2003 Feb; 26(1):30-6. PubMed ID: 12576921
[TBL] [Abstract][Full Text] [Related]
25. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy for pancreatic adenocarcinoma.
Abrams RA
J Gastrointest Surg; 2001; 5(1):6-7. PubMed ID: 11370618
[No Abstract] [Full Text] [Related]
27. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
[TBL] [Abstract][Full Text] [Related]
28. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
29. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
[TBL] [Abstract][Full Text] [Related]
30. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
31. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
Evans DB; Wolff RA; Hess KR
Ann Surg; 2000 Nov; 232(5):727. PubMed ID: 11066157
[No Abstract] [Full Text] [Related]
34. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
Hoffman JP
Ann Surg; 2000 Nov; 232(5):726-7. PubMed ID: 11066156
[No Abstract] [Full Text] [Related]
35. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
36. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
37. [Pancreatic cancer. The relative importance of neoadjuvant therapy].
Beger HG; Poch B; Schwarz M; Gansauge F
Chirurg; 2003 Mar; 74(3):202-7. PubMed ID: 12647076
[TBL] [Abstract][Full Text] [Related]
38. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
[TBL] [Abstract][Full Text] [Related]
39. [Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma].
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Bibeau F; Scoazec JY
Cancer Radiother; 2011 Apr; 15(2):97-105. PubMed ID: 21084206
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
